Reaction

Instillation Site Discharge reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 263 reports · 2 co-occurring drugs

As of the last recalculation, Instillation Site Discharge appears in 263 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is LIFITEGRAST (PRR 1,035.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Lifitegrast1181,035.91,043.5
Vibegron550.350.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.